161 related articles for article (PubMed ID: 6390963)
1. [Effect of parmidin on the course of tuberculosis under isoniazid therapy].
Solov'eva IP; Makinskiĭ AI
Vrach Delo; 1984 Sep; (9):70-3. PubMed ID: 6390963
[No Abstract] [Full Text] [Related]
2. [Mechanism of action of the antikinin preparation pyridinolcarbamate on the development of experimental tuberculosis].
Makinskiĭ AI; Solov'eva IP; Braude VI
Probl Tuberk; 1984 May; (5):60-5. PubMed ID: 6739480
[No Abstract] [Full Text] [Related]
3. [Growth and metastasis of Lewis' lung carcinoma in mice under the pharmacological action on metabolism and the effects of kinins].
Veksler IG; Riabukha VN; Chubinskaia SG; Shvarts GIa
Biull Eksp Biol Med; 1987 Jul; 104(7):79-81. PubMed ID: 3620655
[TBL] [Abstract][Full Text] [Related]
4. [Antagonism of parmidin to kinin effects].
Shvarts GIa; Faermark IF; Siubaev RD
Farmakol Toksikol; 1985; 48(6):37-41. PubMed ID: 4085627
[TBL] [Abstract][Full Text] [Related]
5. [Use of antikinin preparations as pathogenetic agents in the overall therapy of tuberculosis].
Makinskiĭ AI
Probl Tuberk; 1978 Apr; (4):70-4. PubMed ID: 349551
[No Abstract] [Full Text] [Related]
6. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
[No Abstract] [Full Text] [Related]
7. [Use of prodectin in pulmonary tuberculosis].
Safarov RN; Makinskiĭ AI
Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
[No Abstract] [Full Text] [Related]
8. [Basis for prescribing bradykinin antagonists in neurodermatitis and data on the therapeutic effectiveness of parmidin in this dermatosis].
Grebennikov VA
Vestn Dermatol Venerol; 1982 Sep; (9):46-9. PubMed ID: 7180192
[No Abstract] [Full Text] [Related]
9. [Use of isoniazid with nitrofuran and 5-NHQ derivatives in experimental tuberculosis].
Il'ina TB; Vishnevskiĭ BI; Efremova IIa; Vavilin GI
Probl Tuberk; 1976; (8):51-5. PubMed ID: 826902
[No Abstract] [Full Text] [Related]
10. [Prodectin in the treatment of viral hepatitis].
Kozhukhova EA; Iakushin AI; Zakharova VI; Mebel' BD; Larionov GM
Sov Med; 1983; (10):96-7. PubMed ID: 6658556
[No Abstract] [Full Text] [Related]
11. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
Matiashina GI
Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of pyridinolcarbamate in the overall treatment of infiltrative and cavernous-fibrous pulmonary tuberculosis].
Makinskiĭ AI; Safarov RN; Fondaminskaia LD; Semenova AS; Fedotova NN
Probl Tuberk; 1979 Jan; (1):26-30. PubMed ID: 368764
[No Abstract] [Full Text] [Related]
13. [Indications for using antikinin preparations and blood kinin system activators in the combined treatment of pulmonary tuberculosis].
Makinskiĭ AI
Probl Tuberk; 1981 Oct; (10):33-7. PubMed ID: 7312848
[No Abstract] [Full Text] [Related]
14. [Levamisole treatment of experimental tuberculosis].
Aleksandrova AE; Zabolotnykh NV
Probl Tuberk; 1981 Oct; (10):55-8. PubMed ID: 7312854
[No Abstract] [Full Text] [Related]
15. [Effect of riboxine, levamisole and sodium oxybutyrate on the course of experimental tuberculosis].
Aleksandrova AE; Shcherbakova NM; Borisova LE; Zabolotnykh NV
Probl Tuberk; 1988; (3):56-60. PubMed ID: 3290889
[No Abstract] [Full Text] [Related]
16. [Dynamics of the experimental tuberculous process under the influence of nerobol].
Gomoliako IV; Bal'tseva LB; Klimenko MT
Probl Tuberk; 1980 Jan; (1):60-3. PubMed ID: 7367427
[No Abstract] [Full Text] [Related]
17. [Effect of prodectin on the activity of the blood kallikrein-kinin system in diffuse toxic goiter].
Oleĭnik VA; Matiashina GI
Probl Endokrinol (Mosk); 1986; 32(4):7-10. PubMed ID: 3639497
[TBL] [Abstract][Full Text] [Related]
18. [Effect of phthivazid and isoniazid on the macro- and microorganisms in tubercular infections].
Sodikov ES; Kazakov KS; Gapon'ko LA
Probl Tuberk; 1970; 48(8):58-61. PubMed ID: 4924910
[No Abstract] [Full Text] [Related]
19. [The comparative characteristics of the antiatherogenic effect of xymedon and parmidine].
Kamburg RA; Ibragimov OB; Kondrat'eva MB; Valeeva IKh; Shamsutdinov NSh
Biull Eksp Biol Med; 1993 Aug; 116(8):205-8. PubMed ID: 8274706
[TBL] [Abstract][Full Text] [Related]
20. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
Parodi FA; Caputo G
Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
